Case Study Framework: Presenting Sustainable Process Improvements to FDA/EMA Reviewers in 2023 Case Study Framework: Presenting Sustainable Process Improvements to FDA/EMA Reviewers in 2023 In the rapidly evolving landscape of pharmaceutical regulations, demonstrating sustainability in processes has become increasingly paramount. This guide aims to provide a detailed, step-by-step framework on how to successfully present sustainable process improvements to FDA and EMA reviewers, addressing the current regulations and standards expected in 2023. This is particularly important for organizations dedicated to environmental, health, and safety (EHS) compliance consulting. Step 1: Understanding Regulatory Context and Frameworks The first step in presenting sustainable process…

Managing Genotoxic Impurity Risk When Changing Solvents for Sustainability in 2023 Managing Genotoxic Impurity Risk When Changing Solvents for Sustainability in 2023 As industries pivot towards sustainable practices, the significance of integrating green chemistry principles while adhering to regulatory compliance becomes paramount. In the context of solvent substitution, understanding the implications of genotoxic impurities is crucial for pharmaceutical companies. This article outlines a step-by-step approach to managing genotoxic impurity risk when changing solvents, focusing on practical actions, documentation expectations, and regulatory guidelines. Step 1: Understanding Genotoxic Impurities and Their Risks Before embarking on solvent changes, it is essential to grasp…